Trandolapril; Verapamil Hydrochloride was first introduced by Abbvie Inc in its drug Tarka on Oct 22, 1996. 2 different companies have introduced drugs containing Trandolapril; Verapamil Hydrochloride.

Trandolapril; Verapamil Hydrochloride Patents

Given below is the list of patents protecting Trandolapril; Verapamil Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Tarka	US5721244	Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs	Feb 24, 2015 (Expired)	Abbvie

Add above patents to watchlist

Trandolapril; Verapamil Hydrochloride's Family Patents

Unlock Global Patents

Trandolapril; Verapamil Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Trandolapril; Verapamil Hydrochloride.

Given below is the list of companies who have filed for Trandolapril; Verapamil Hydrochloride generic, along with the locations of their manufacturing plants worldwide.